Transjugular intrahepatic portosystemic shunt for recompensating decompensated cirrhosis?

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Karagiannakis DS;Karagiannakis DS
  • Source:
    World journal of gastroenterology [World J Gastroenterol] 2024 May 28; Vol. 30 (20), pp. 2621-2623.
  • Publication Type:
    Editorial
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 100883448 Publication Model: Print Cited Medium: Internet ISSN: 2219-2840 (Electronic) Linking ISSN: 10079327 NLM ISO Abbreviation: World J Gastroenterol Subsets: MEDLINE
    • Publication Information:
      Publication: 2014- : Pleasanton, CA : Baishideng Publishing Group
      Original Publication: Beijing : WJG Press, c1998-
    • Subject Terms:
      Ascites*/etiology ; Ascites*/surgery ; Esophageal and Gastric Varices*/surgery ; Esophageal and Gastric Varices*/etiology ; Gastrointestinal Hemorrhage*/etiology ; Gastrointestinal Hemorrhage*/surgery ; Gastrointestinal Hemorrhage*/prevention & control ; Liver Cirrhosis*/complications ; Liver Cirrhosis*/surgery ; Portasystemic Shunt, Transjugular Intrahepatic*/methods ; Portasystemic Shunt, Transjugular Intrahepatic*/adverse effects; Humans ; Hypertension, Portal/surgery ; Hypertension, Portal/etiology ; Treatment Outcome
    • Abstract:
      Transjugular intrahepatic portosystemic shunt (TIPS) is a medical procedure that has been used to manage variceal bleeding and ascites in patients with cirrhosis. It can prevent further decompensation and improve the survival of high-risk decompensated patients. Recent research indicates that TIPS could increase the possibility of recompensation of decompensated cirrhosis when it is combined with adequate suppression of the causative factor of liver disease. However, the results of the studies have been based on retrospective analysis, and further validation is required by conducting randomized controlled studies. In this context, we highlight the limitations of the current studies and emphasize the issues that must be addressed before TIPS can be recommended as a potential recompensating tool.
      Competing Interests: Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
      (©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.)
    • References:
      J Vasc Interv Radiol. 2000 Jul-Aug;11(7):913-8. (PMID: 10928532)
      JHEP Rep. 2021 Jun 04;3(4):100316. (PMID: 34337369)
      Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861. (PMID: 35798021)
      World J Gastroenterol. 2023 Oct 14;29(38):5383-5394. (PMID: 37900585)
      Curr Pharm Des. 2018;24(38):4574-4586. (PMID: 30652642)
      Hepatology. 2024 Apr 1;79(4):869-881. (PMID: 37916970)
      World J Gastroenterol. 2024 Mar 28;30(12):1777-1779. (PMID: 38617737)
      J Interv Med. 2022 Sep 14;5(4):207-212. (PMID: 36532306)
      Clin Liver Dis. 2016 Nov;20(4):667-679. (PMID: 27742006)
      J Hepatol. 2023 Sep;79(3):692-703. (PMID: 37141993)
      Hepatology. 2002 Mar;35(3):630-4. (PMID: 11870377)
      Hepatology. 2024 Mar 1;79(3):535-537. (PMID: 38085849)
      J Hepatol. 2022 Apr;76(4):959-974. (PMID: 35120736)
    • Contributed Indexing:
      Keywords: Baveno VII; Decompensated cirrhosis; Liver recompensation; Transjugular intrahepatic portosystemic shunt
    • Publication Date:
      Date Created: 20240610 Date Completed: 20240610 Latest Revision: 20241212
    • Publication Date:
      20241213
    • Accession Number:
      PMC11154674
    • Accession Number:
      10.3748/wjg.v30.i20.2621
    • Accession Number:
      38855160